CD1D and neoplasm: In Jα18−/− mice, C. crescentus treatment significantly slowed both EL4 and B16 tumor growth compared to WT, suggesting type I NKT cells have an immunomodulatory role against CD1d-restricted NKT cells that prevents antitumor activity [383].